Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107146

Growth Hormone: Metabolic Clearance Rates, Integrated Concentrations, and Production Rates in Normal Adults and the Effect of Prednisone

Robert G. Thompson, Ana Rodriguez, Avinoam Kowarski, and Robert M. Blizzard

Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Find articles by Thompson, R. in: PubMed | Google Scholar

Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Find articles by Rodriguez, A. in: PubMed | Google Scholar

Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Find articles by Kowarski, A. in: PubMed | Google Scholar

Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Find articles by Blizzard, R. in: PubMed | Google Scholar

Published December 1, 1972 - More info

Published in Volume 51, Issue 12 on December 1, 1972
J Clin Invest. 1972;51(12):3193–3199. https://doi.org/10.1172/JCI107146.
© 1972 The American Society for Clinical Investigation
Published December 1, 1972 - Version history
View PDF
Abstract

A constant withdrawal pump was used to determine the integrated concentration of growth hormone (ICGH) which was used in conjunction with the metabolic clearance rate (MCR) of growth hormone (GH) to calculate the GH production rates (GHPR) in normal adults, acromegalics, and normal controls receiving prednisone.

The mean ICGH for 22 premenopausal females on no medication was 3.0±1.6 ng/ml (sd) which is significantly lower (P < 0.005) than the mean of 6.6±2.9 for 10 women receiving oral contraceptives and significantly higher than the means of 1.5±0.75 for 5 postmenopausal females (P < 0.05) and 1.8±1.0 for 16 adult males (P < 0.01) which are comparable. The mean GHPR's in mg/24 hr per m2 for the four groups are: normal females = 0.52±0.24 (sd), females receiving contraceptive pills = 1.65±0.58 (P < 0.005), postmenopausal females = 0.26±0.12 (P < 0.025), and adult males 0.35±0.23 (P < 0.025).

Three untreated acromegalic patients had ICGH's of 59, 82, and 93 ng/ml and GHPR's ranging from 14.5 to 17.9 mg/24 hr.

Prednisone in a dose of 20 mg t.i.d. for 8 days significantly decreased both the ICGH and GHPR. Alternate day prednisone (60 mg in a single q.o.d. dose) resulted in less consistent inhibition of GH release which may play a role in the more normal growth seen in children receiving q.o.d. prednisone.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 3193
page 3193
icon of scanned page 3194
page 3194
icon of scanned page 3195
page 3195
icon of scanned page 3196
page 3196
icon of scanned page 3197
page 3197
icon of scanned page 3198
page 3198
icon of scanned page 3199
page 3199
Version history
  • Version 1 (December 1, 1972): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts